Veradigm | Frais De Vente Et D'Administration



Selling And Administration Expenses Changement Date
Alcidion AUD 13.85M 6.34M 2024-12
Ambu A/S DKK 630M 27M 2025-03
Cardinal Health USD 1.32B 9M 2025-03
Centene USD 3.35B 129M 2025-03
Charles River Laboratories USD 177.8M 10.46M 2025-03
Cigna USD 4B 230M 2025-03
Convatec Group 420.3M 210.35M 2024-12
CVS Health USD 10.52B 22M 2024-12
Diasorin EUR 102M 18.04M 2024-09
Elevance Health USD 10.74B 376M 2024-12
General Electric USD 876M 281M 2025-03
Gulf Medical Proj AED 29.91M 1.27M 2025-03
Humana 3.97B 631M 2024-12
IQVIA Holdings USD 508M 55M 2025-03
Kora Saude BRL 45.6M 10.33M 2024-12
Laboratory Of America USD 546M 49.2M 2025-03
Maximus USD 162.86M 28.88M 2025-03
McKesson USD 1.97B 54M 2025-03
Med Life RON 25.65M 158.01M 2024-12
Molina Healthcare USD 1.16B 114M 2025-03
Omnicell USD 102.03M 1.21M 2025-03
Oriola-kd EUR 14.1M 1.3M 2024-12
Owens Minor USD 462.35M 30.72M 2025-03
Quest Diagnostics USD 476M 10M 2025-03
Rede D'or Sao Luiz BRL 408.78M 5.51M 2025-03
Siemens Healthineers EUR 991M 18M 2025-03
Sonova Holding CHF 879.9M 48.8M 2024-09
UnitedHealth USD 13.59B 1.1B 2025-03
Veeva Systems USD 165.94M 1.11M 2025-01
Walgreens Boots Alliance USD 6.49B 2.4B 2025-05
Xerox USD 378M 1000K 2025-03



Veradigm Frais De Vente Et D'Administration - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Jul 2025.